Connect with us


Senior Trump and Biden officials knew for months about problems at vaccine plant – POLITICO

A new analysis raises questions about whether more could have been done to prevent a contamination that ruined more than 15 million vaccine doses.



Article feature image

The analysis, which came on the heels of an April 2020 inspection by the Food and Drug Administration, said Emergent only had a fraction of the necessary experienced personnel to oversee quality control and technology transfer operations for Covid-19 vaccine production. The company had already agreed to manufacture J&Js vaccine and was negotiating a similar deal with AstraZeneca.
The saga underscores the United States lack of contract manufacturing capacity to produce critical life-saving drugs…

Click here to view the original article.

Continue Reading

You might also like ...

Article feature image
$1,400 stimulus checks helped March retail sales soar 9.8% – The Associated Press
Article feature image
BAC Stock: Bank Of America Earnings Beat On Reserves, Investment Banking; Citigroup Earnings Top – Investor’s Business Daily
Article feature image
5 things to know before the stock market opens Thursday – CNBC